Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control

Area of Science:

• Immunology
• Cancer Biology
• T cell Regulation

Background:

• CD4 T cells are crucial for anti-cancer immunity and immunotherapy.
• The regulation of CD4 tumor-specific T (T_TS) cells during cancer progression is not well understood.

Purpose of the Study:

• To investigate the regulatory mechanisms controlling CD4 T_TS cell proliferation and function in the tumor microenvironment.
• To determine the impact of regulatory T cells and CTLA4 on CD4 T_TS cell activity.
• To explore the therapeutic potential of overcoming CD4 T_TS cell suppression.

Main Methods:

• Tumor initiation models in mice.
• Flow cytometry and single-cell RNA sequencing to analyze T cell populations.
• In vivo experiments manipulating regulatory T cell function and CTLA4 blockade.

Main Results:

• CD4 T_TS cells are primed and proliferate early after tumor initiation.
• Regulatory T cells and CTLA4 rapidly inhibit CD4 T_TS cell proliferation and differentiation.
• This suppression involves metabolic reprogramming and reduced tumor infiltration.
• Alleviating suppressive constraints restores CD4 T_TS cell function and leads to tumor control.

Conclusions:

• CD4 T_TS cell activity is actively suppressed by regulatory T cells and CTLA4, contributing to tumor progression.
• Overcoming this suppression can re-establish anti-tumor immunity and achieve long-term tumor control.
• Targeting these regulatory mechanisms represents a promising therapeutic strategy in cancer immunotherapy.